From Nasdaq: 2025-02-14 17:45:11

Hims & Hers Health, Inc. (HIMS) closed at $60.30, up 1.88% from the previous session, outperforming the S&P 500. The stock has risen by 111.81% in the past month, surpassing the Medical sector and S&P 500 gains.

Analysts anticipate HIMS to report an EPS of $0.12 on February 24, 2025, a 1100% increase from last year. Revenue is estimated at $471.42 million, up 91.15%. Positive estimate revisions indicate confidence in the company’s performance and profit potential.

The Zacks Rank system, which rates stocks from #1 (Strong Buy) to #5 (Strong Sell), shows HIMS currently at #3 (Hold). With a Forward P/E ratio of 112.88, the stock trades at a premium compared to its industry’s ratio of 33.65.

HIMS is part of the Medical Info Systems industry within the Medical sector, ranked at 82 out of over 250 industries. Top-ranked industries historically outperform the bottom half by a 2 to 1 ratio. Stay updated on HIMS with Zacks.com.

Zacks Investment Research has released 7 elite stocks from 220 Zacks Rank #1 Strong Buys, expected to see early price pops. Since 1988, this list has outperformed the market with an average annual gain of +24.3%. Get immediate access to these stocks for potential returns.



Read more at Nasdaq: Hims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to Note